Schonfeld Strategic Advisors LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,568
-58.5%
26,600
-24.9%
0.00%
-100.0%
Q3 2022$64,000
-65.8%
35,400
-45.0%
0.00%
-50.0%
Q2 2022$187,000
-8.8%
64,400
-13.4%
0.00%0.0%
Q1 2022$205,000
+41.4%
74,400
+138.5%
0.00%
+100.0%
Q4 2021$145,000
-93.0%
31,200
-87.1%
0.00%
-95.2%
Q3 2021$2,058,000241,7610.02%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders